Reneuron Group (RENE)

 

RENE Share PerformanceMore

52 week high275.00 22/02/17
52 week low100.00 13/02/18
52 week change -159.00 (-60.57%)
4 week volume1,657,918 24/01/18
price103.50
price date1519055660
close103.50

Media for (RENE)

Presenter: Michael Hunt, CEO
04/02/2015

Latest NewsMore

Block Listing Application

RNS Number: 0611F ReNeuron Group plc 16 February 2018 16 February 2018 AIM: RENE ReNeuron Group plc ("ReNeuron" or "the Company") Block Listing Application ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, today announces that an application has been made to the London Stock Exchange plc ...

Positive pre-clinical data in nerve injury

RNS Number: 7283E ReNeuron Group plc 13 February 2018 13 February 2018 AIM: RENE ReNeuron Group plc ("ReNeuron" or the "Company") Positive pre-clinical data in nerve injury Positive pre-clinical data published using ReNeuron's CTX cells in artificial nerve tissue generated as part of a grant-funded collaboration ReNeuron Group plc (AIM: RENE), a UK...

ReNeuron presents treatment trial results

ReNeuron Group said that positive long-term clinical trial data for a stroke disability treatment was accepted for a podium...

Phase II stroke data presented at AHA conference

RNS Number: 9885C ReNeuron Group plc 26 January 2018 26 January 2018 AIM: RENE RNS REACH ReNeuron Group plc ("ReNeuron" or the "Company") Phase II stroke data presented at AHA conference Positive long-term data from Phase II stroke disability clinical trial accepted for a late-breaking podium presentation at the American Heart Association Intern...

ReNeuron shareholders approval capital re-organisation

ReNeuron Group said shareholders had approved a re-organisation of its share capital at a general meeting. All shareholde...

Further re Share Capital Reorganisation

RNS Number: 5473B ReNeuron Group plc 11 January 2018 11 January 2018 AIM: RENE ReNeuron Group plc ("ReNeuron" or the "Company") Share Capital Reorganisation - Allotment of Ordinary Shares & Irrevocable Undertaking Capitalised terms not otherwise defined herein shall have the same meaning given to such terms in the circular issued by the Compan...

ReNeuron Group plans share reduction

ReNeuron Group has launched a capital reorganisation what will reduce the number of shares in the company by a facto...

Proposed Share Capital Reorganisation

RNS Number: 0371B ReNeuron Group plc 05 January 2018 5 January 2018 AIM: RENE ReNeuron Group plc ("ReNeuron" or the "Company") Proposed Share Capital Reorganisation and Notice of General Meeting Share consolidation to increase the price of each share to improve marketability, liquidity and trading activity ReNeuron Group plc (AIM: RENE), a UK...

Fundamental DataMore

EPS-0.5
Dividend yield0 %

Latest discussion posts More

  • Re: bit of info - head of manufacturing

    That would be good news mol.....gateway to a much-needed revenue stream!
    19-Feb-2018
    fredd1eboy
  • bit of info - head of manufacturing

    new appointment from Feb 18 http://uk.linkedin.com/in/carl-jones-237b2112 well at least progress re the licence presumably - news perhaps soon? mol
    18-Feb-2018
    mol42
  • Re: bit of buying today

    why did i top up today? after some readers, may find my subsequent posts, harsh on company - nothing i haven't commented on before because i still believe we, in our ...
    16-Feb-2018
    mol42

Users' HoldingsMore

Users who hold Reneuron Group also hold..

Codes & Symbols

ISINGB00BF5G6K95
SymbolsRENE, LSE:RENE, RENE.L, RENE:LN, LON:RENE, XLON:RENE

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account